Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ALLOPURINOL
- Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia
- The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients With Cardiovascular Risk
- Allopurinol Improves Heart Function in African Americans With Resistant Hypertension
- Allopurinol and Quality of Life
- Phase 2b/3 Study to Assess Efficacy and Safety of ABP-671 a Novel URAT1 Inhibitor in Participants With Gout
- BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation
- Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia
- Phase II Study to Evaluate Efficacy and Safety of D-0120 Administered in Combination With Allopurinol in Subjects With Gout
- Effect of Allopurinol on Markers of Mineral and Bone Metabolism
- A Phase 3 Study to Assess the Safety and Efficacy of 12 Months Treatment With Tigulixostat Compared to Allopurinol in Gout Patients With Hyperuricemia
- Allopurinol to Prevent Cirrhosis Related Morbidities
- Allopurinol and Trimetazidine as a Preventive of Acute Kidney Injury in PCI Patients
- Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)
- Allopurinol Versus Simvastatin to Prevent Complications of Liver Cirrhosis
- An Innovative Chinese Herbal Formula for the Treatment of Gout
- Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients
- Allopurinol Effect on MDA,NO,KIM-1 Urine Levels, RI and Renal Elastography in Kidney Stone Patients Post ESWL
- Evaluation of PK and Safety of D-0120 and Allopurinol
- Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout
- Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo
- Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration
- Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial)
- Crossover Clinical Trial, Randomized, Double Blind, Placebo Controlled Trial
- A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With Gout
- Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
- Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
- Obesity and Uric Acid Stones Study
- A Study in Healthy Subjects to Assess Drug Availability of 4 Different Formulations of Verinurad and Allopurinol
- Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers
- Management of Prostatodynia in Younger Patients With Non-ablative Erbium:YAG Intraurethral Laser
- Allopurinol in Patients With Refractory Angina to Improve Ischemic Symptoms
- The WWRD Study: AVM0703 for Treatment of Leukemia or Lymphoma
- Study of Verinurad in Heart Failure With Preserved Ejection Fraction
- A Study to Assess the Effect of Verinurad on the Electric Activity of the Heart
- Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass
- Phase 2a Study of AR882 Alone and in Combination With Febuxostat or Allopurinol in Gout Patients
- A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout
- Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm
- Effects of Allopurinol on Inflammation and Ultrasonographic Changes in People With Elevated Uric Acid But no Symptoms
- A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia
- Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease
- A Study to Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese Subjects
- Evaluation of a Treatment With Allopurinol in Adenylosuccinate Lyase Deficiency
- Effect of Allopurinol or Febuxostat to Prevent Contrast Induced Acute Kidney Injury (CI-AKI)
- Allopurinol in Acute Coronary Syndrome
- Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease
- The Effect of Local Antioxidant Therapy on Racial Differences in Vasoconstriction
- Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric Acid
- Bendamustine/Rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia
- The Percentage of Cases of Acute Treatment With Allopurinol in Gout Patients
- A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion
- Use of Venetoclax as Single Agent in Patients With Relapsed/Refractory BCL-2 Positive Peripheral T Cell Lymphoma
- Comparative Clinical Efficacy and Safety of Coded Polyherbal Medicine for the Management of Arthritis
- Allopurinol and Endothelial Function in Diabetic CAD Patients
- Lowering Uric Acid in Live Kidney Donors
- The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF)
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence.
- A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment
- Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL)
- Effect of Allopurinol on Mono and Co-administration With Statins on Platelets Reactivity on Diabetic Patiets Treated With Aspirin and Insulin
- Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome
- Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
- Venetoclax and Ibrutinib in Treating Participants With High-Risk Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative Colitis
- Gender Differences in the Metabolic Effects of Uric Acid
- Allopurinol in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
- The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics
- Assessment of the Safety, Tolerability and Pharmacodynamics After Administration of One Dose of AZD8601 to Male Patients With Type II Diabetes Mellitus (T2DM)
- Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence
- Effect of Febuxostat on Endothelial Dysfunction in Hemodialysis Patients.
- Microalbuminuria and Allopurinol in Type 1 Diabetes
- Investigation of the Atherogenic Effects of Uric Acid-modified in Endothelial Dysfunction and the the Preventional Mechanism by Anthocyanidines
- Effect of Allopurinol and Febuxostat on Urinary 2,8-Dihydroxyadenine Excretion
- Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Plus Allopurinol in Healthy Volunteers
- Allo HSCT Using RIC for Hematological Diseases
- Zurig (Febuxostat) 40mg Efficacy and Safety Trial
- Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability
- CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat
- Role of Allopurinol on Oxidative Stress and Mitochondrial Alterations in Skeletal Muscle of Diabetic Patients
- Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes
- Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout
- Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects
- Optimal Administration of Allopurinol in Dialysis Patients
- IVIVR Assessing PK Parameters Used to Establish Bioequivalence
- Genetics of Hyperuricemia Therapy in Hmong
- RDEA3170 and Allopurinol Combination Study in Gout Subjects
- Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension?
- Randomized Phase III Study of Decitabine +/- Hydroxyurea (HY) Versus HY in Advanced Proliferative CMML
- Prednisone for Heart Failure Patients With Hyperuricemia
- XILO-FIST, the Effect of Allopurinol on the Brain Heart and Blood Pressure After Stroke
- Safety and Efficacy of Oral Febuxostat in Subjects With Gout
- Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia
- A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL
- A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
- Center of Research Translation (CORT) Project 2
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
- Effect of Allopurinol Treatment on Insulin Resistance
- Does Allopurinol Prolong a Treated, Acute Gout Flare?
- Effect of Allopurinol Administration on the Prevention of Muscle Mass Loss in Subject Immobilized.
- Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study
- Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer
- Lesinurad and Allopurinol Combination Extension Study in Gout
- Allopurinol in Acute Gout
- Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL
- A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout
- Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
- Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies
- The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study
- Busulfan and Cyclophosphamide Followed By ALLO BMT
- Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome
- Efficacy Study of Hypothermia Plus Magnesium Sulphate(MgSO4) in the Management of Term and Near Term Babies With Hypoxic Ischemic Encephalopathy
- Study of Cardiovascular Disease and Obstructive Sleep Apnea
- Effectiveness Allopurinol Topical Agent Prevention Capecitabine-induced Hand-foot Syndrome
- Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
- Bioequivalence Study of Allopurinol 300 mg Tablets USP Under Fasting Condition
- A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
- Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies
- Allopurinol in Functional Impairment (ALFIE) Trial: 'Improving Muscle Strength'
- Phase 2 Study of the Combination of Bruton's Tyrosine Kinase Inhibitor PCI-32765 and Rituximab in High-Risk Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients
- Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
- Combining Lesinurad With Allopurinol in Inadequate Responders
- Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
- Combining Lesinurad With Allopurinol in Inadequate Responders
- T-Cell Depleted Double UCB for Refractory AML
- Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
- Allopurinol in Acute Coronary Syndrome
- Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol
- Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)
- Phase II Study of Ofatumumab in Elderly Patients With Chronic Lymphocytic Leukemia (CLL)
- A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency
- Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
- Allopurinol Outcome Study
- Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)
- PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years
- Xanthine Oxidase Inhibition in Renal Transplant Recipients
- Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)
- Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function
- Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout
- Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol
- Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
- Uric Acid and the Endothelium in CKD
- Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2
- Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)
- Hyperuricemia on Hypertension and Metabolic Syndrome
- Allopurinol as a Possible Oxygen Sparing Agent During Exercise in Peripheral Arterial Disease
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout
- Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)
- Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
- Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies
- Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode
- Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
- Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones
- Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia
- Impact of Diabetes on Left Ventricular Remodeling
- Allopurinol Combination Study
- Allopurinol in Chronic Heart Failure
- Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
- The Effect of Uric Acid Decrement on Endothelial Function in Patients With Chronic Renal Failure
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations (PRE-SURGE 2)
- Trial of Kuvan in Lesch-Nyhan Disease
- Prednisone for Heart Failure Patients With Hyperuricemia
- Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)
- Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia
- A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies
- Azathioprine & Allopurinol in Inflammatory Bowel Disease Patients
- PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1
- An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia
- Phase III Trial of Febuxostat in Korea Gout Patients
- A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)
- A Controlled Study of Uric Acid on the Progression of IgA Nephropathy
- Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen
- Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
- Allopurinol Maintenance Study for Bipolar Disorder
- Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis
- Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?
- Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer
- Allopurinol Add-on Treatment for Refractory Mania
- The Effect of Allopurinol on Insulin Resistance and Blood Pressure
- Rasburicase (Fasturtec) Registration Trial
- T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
- Efficacy of Allopurinol and Dypiridamole in Acute Mania
- Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older
- CFAR Study in Patients With Chronic Lymphocytic Leukemia
- Correlation of Genetic Polymorphism of Azathioprine Metabolizing Enzymes and Correlation to Clinical Adverse Effects
- Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
- APEX Study: Effects of Allopurinol on Coronary and Peripheral Endothelial Function in Patients With Cardiac Syndrome X
- Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol
- Effects of Allopurinol on Diastolic Function in Chronic Heart Failure Patients
- a Phase II Study in Primary Central Nervous System Lymphoma
- Efficacy and Safety of Oral Febuxostat in Participants With Gout
- Efficacy Study of Glyceryl-Trinitrate Patch and Parecoxib (Valdecoxib) for the Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography (ERCP)
- A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas
- Antenatal Allopurinol in Intrauterine Growth Restriction
- Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis
- Uric Acid in Essential Hypertension in Children
- Allopurinol for Renal Transplant Associated Hypertension in Children
- Primary Prevention of Hypertension in Obese Adolescents
- Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy
- Uric Acid and Hypertension in African Americans
- Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome
- Vascular Pathophysiology in Obstructive Sleep Apnea
- A Clinical Double Blind, Randomized Study of the Efficacy of Hyperuricemia Treatment With Anserine Product.
- Pharmacokinetic Study of Marine Active in Health Men
- Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma
- Antenatal Allopurinol During Fetal Hypoxia
- Intravenous Allopurinol in Heart Failure
- Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010
- Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout
- Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.
- Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation
- S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Febuxostat Versus Allopurinol Control Trial in Subjects With Gout
- Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
- Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer
- Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
- Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil
- Phase II Pilot Study of Aminoimidazole Carboxamide Riboside (AICAR), a Precursor of Purine Synthesis, for Lesch-Nyhan Disease
- Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
- Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members
- A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma
Clinical trials list
click for details